Bruce Jackson
Stock Analyst at Benchmark
(1.06)
# 3,827
Out of 5,042 analysts
123
Total ratings
29.46%
Success rate
-17.78%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Initiates: Buy | $145 | $123.62 | +17.29% | 1 | Oct 10, 2025 | |
| CV CapsoVision | Initiates: Speculative Buy | $5 | $4.88 | +2.46% | 1 | Jul 28, 2025 | |
| BFRI Biofrontera | Maintains: Buy | $7 → $2.75 | $1.10 | +150.00% | 8 | May 19, 2025 | |
| HUMA Humacyte | Maintains: Buy | $17 → $14 | $1.67 | +738.32% | 15 | May 14, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $4.5 → $3 | $0.52 | +480.72% | 6 | May 13, 2025 | |
| CLNN Clene | Maintains: Buy | $84 → $33 | $12.50 | +164.00% | 8 | May 8, 2025 | |
| GNLX Genelux | Maintains: Speculative Buy | $25 → $23 | $8.08 | +184.65% | 7 | May 8, 2025 | |
| BLTE Belite Bio | Reiterates: Buy | $80 | $105.91 | -24.46% | 9 | Mar 26, 2025 | |
| NEO NeoGenomics | Reiterates: Hold | n/a | $9.77 | - | 8 | Jan 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $65 | $64.69 | +0.48% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $0.43 | - | 3 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $4.75 | +531.58% | 8 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1.25 | $0.42 | +197.97% | 2 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $3 | $1.42 | +111.27% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $2.20 | +127.27% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $300 | $5.70 | +5,163.16% | 2 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $60 | $4.04 | +1,385.15% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $17 | $0.60 | +2,734.75% | 4 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $1.20 | +1,900.00% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $0.49 | +910.31% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.43 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $25.87 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $3.05 | +26,129.51% | 1 | Aug 8, 2022 |
Abbott Laboratories
Oct 10, 2025
Initiates: Buy
Price Target: $145
Current: $123.62
Upside: +17.29%
CapsoVision
Jul 28, 2025
Initiates: Speculative Buy
Price Target: $5
Current: $4.88
Upside: +2.46%
Biofrontera
May 19, 2025
Maintains: Buy
Price Target: $7 → $2.75
Current: $1.10
Upside: +150.00%
Humacyte
May 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $1.67
Upside: +738.32%
Harvard Bioscience
May 13, 2025
Maintains: Speculative Buy
Price Target: $4.5 → $3
Current: $0.52
Upside: +480.72%
Clene
May 8, 2025
Maintains: Buy
Price Target: $84 → $33
Current: $12.50
Upside: +164.00%
Genelux
May 8, 2025
Maintains: Speculative Buy
Price Target: $25 → $23
Current: $8.08
Upside: +184.65%
Belite Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $80
Current: $105.91
Upside: -24.46%
NeoGenomics
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $9.77
Upside: -
Exact Sciences
Jan 13, 2025
Reiterates: Buy
Price Target: $65
Current: $64.69
Upside: +0.48%
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.43
Upside: -
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $4.75
Upside: +531.58%
Nov 20, 2024
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.42
Upside: +197.97%
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $1.42
Upside: +111.27%
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.20
Upside: +127.27%
Sep 4, 2024
Reiterates: Speculative Buy
Price Target: $300
Current: $5.70
Upside: +5,163.16%
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $60
Current: $4.04
Upside: +1,385.15%
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $0.60
Upside: +2,734.75%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $1.20
Upside: +1,900.00%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $0.49
Upside: +910.31%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.43
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $25.87
Upside: -
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $3.05
Upside: +26,129.51%